Clinical trial

Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy

NCT05418465

Study summary

ClinicalTrials.gov

Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Huangqi Guizhi Wuwu decoction Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Dapagliflozin Normalized identity: dapagliflozin View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-01-26

PhaseNA

Conditions

Diabetic Nephropathiesunresolved

Interventions

Huangqi Guizhi Wuwu decoctionDRUG

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

Sponsors & collaborators

The First Affiliated Hospital of Dalian Medical Universitylead sponsor

Mapped research locations

DalianLiaoning, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05418465 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.